Viagra: Effective Treatment for Erectile Dysfunction and Pulmonary Hypertension - Evidence-Based Review
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.51 | $45.07 (0%) | 🛒 Add to cart |
| 20 | $2.75 | $90.14 $55.08 (39%) | 🛒 Add to cart |
| 30 | $2.17 | $135.21 $65.10 (52%) | 🛒 Add to cart |
| 60 | $1.50 | $270.41 $90.14 (67%) | 🛒 Add to cart |
| 90 | $1.45 | $405.62 $130.20 (68%) | 🛒 Add to cart |
| 120 | $1.34 | $540.83 $160.25 (70%) | 🛒 Add to cart |
| 180 | $1.22 | $811.24 $220.34 (73%) | 🛒 Add to cart |
| 270 | $1.11 | $1216.87 $300.46 (75%) | 🛒 Add to cart |
| 360 | $1.00
Best per pill | $1622.49 $360.55 (78%) | 🛒 Add to cart |
| Product dosage: 25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $2.00 | $40.06 (0%) | 🛒 Add to cart |
| 30 | $1.50 | $60.09 $45.07 (25%) | 🛒 Add to cart |
| 60 | $0.92 | $120.18 $55.08 (54%) | 🛒 Add to cart |
| 90 | $0.67 | $180.28 $60.09 (67%) | 🛒 Add to cart |
| 120 | $0.58 | $240.37 $70.11 (71%) | 🛒 Add to cart |
| 180 | $0.45 | $360.55 $80.12 (78%) | 🛒 Add to cart |
| 270 | $0.32 | $540.83 $85.13 (84%) | 🛒 Add to cart |
| 360 | $0.26
Best per pill | $721.11 $95.15 (87%) | 🛒 Add to cart |
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.01 | $40.06 (0%) | 🛒 Add to cart |
| 20 | $2.50 | $80.12 $50.08 (37%) | 🛒 Add to cart |
| 30 | $1.84 | $120.18 $55.08 (54%) | 🛒 Add to cart |
| 60 | $1.34 | $240.37 $80.12 (67%) | 🛒 Add to cart |
| 90 | $1.11 | $360.55 $100.15 (72%) | 🛒 Add to cart |
| 120 | $1.00 | $480.74 $120.18 (75%) | 🛒 Add to cart |
| 180 | $0.83 | $721.11 $150.23 (79%) | 🛒 Add to cart |
| 270 | $0.76 | $1081.66 $205.32 (81%) | 🛒 Add to cart |
| 360 | $0.70
Best per pill | $1442.21 $250.38 (83%) | 🛒 Add to cart |
Synonyms | |||
Similar products
Viagra, known generically as sildenafil citrate, is an oral phosphodiesterase type 5 (PDE5) inhibitor initially developed by Pfizer. It was investigated for angina and hypertension but famously repurposed for erectile dysfunction (ED) after clinical trial participants reported improved erections. It works by enhancing blood flow to the penis during sexual stimulation, facilitating erection. Approved by the FDA in 1998, it revolutionized ED treatment and is now also indicated for pulmonary arterial hypertension (PAH) under the brand name Revatio.
1. Introduction: What is Viagra? Its Role in Modern Medicine
Viagra, or sildenafil citrate, is a prescription medication classified as a phosphodiesterase type 5 (PDE5) inhibitor. It is primarily used to treat erectile dysfunction (ED) in men and pulmonary arterial hypertension (PAH) in adults. Since its approval, Viagra has become one of the most recognized and studied drugs globally, fundamentally changing the management of ED and offering a viable therapeutic option for PAH patients. Its significance lies in its targeted mechanism, which addresses specific physiological pathways with well-documented efficacy.
2. Key Components and Bioavailability of Viagra
The active pharmaceutical ingredient in Viagra is sildenafil citrate. It is formulated in film-coated tablets available in strengths of 25 mg, 50 mg, and 100 mg. Excipients include microcrystalline cellulose, anhydrous dibasic calcium phosphate, croscarmellose sodium, magnesium stearate, hypromellose, titanium dioxide, lactose, triacetin, and synthetic iron oxides.
Bioavailability of oral sildenafil is approximately 40%, with peak plasma concentrations reached within 30 to 120 minutes (median 60 minutes). High-fat meals can delay absorption, reducing maximum concentration by about 30%. Sildenafil is predominantly metabolized by the cytochrome P450 (CYP) enzymes, specifically CYP3A4 (major route) and CYP2C9 (minor route). The major metabolite, N-desmethyl sildenafil, is active and contributes about 20% to the overall pharmacodynamic effects. The terminal half-life is about 4 hours.
3. Mechanism of Action of Viagra: Scientific Substantiation
Sildenafil’s primary mechanism involves selective inhibition of phosphodiesterase type 5 (PDE5). PDE5 is an enzyme that breaks down cyclic guanosine monophosphate (cGMP) in the smooth muscle cells of the corpus cavernosum in the penis and the pulmonary vasculature.
During sexual stimulation, nitric oxide (NO) is released from nerve endings and endothelial cells. NO activates guanylate cyclase, which increases cGMP levels. Elevated cGMP causes smooth muscle relaxation, allowing increased blood flow into the corpus cavernosum, resulting in erection. PDE5 normally degrades cGMP, terminating the signal. Viagra inhibits PDE5, thereby preserving cGMP levels, enhancing and prolonging the erectile response.
In pulmonary arterial hypertension, the same mechanism in the pulmonary vasculature leads to vasodilation, reducing pulmonary vascular resistance and pressure, which improves exercise capacity.
4. Indications for Use: What is Viagra Effective For?
Viagra for Erectile Dysfunction
Viagra is indicated for the treatment of erectile dysfunction, the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. It is effective for ED of various etiologies, including vasculogenic, neurogenic, and psychogenic, and in patients with comorbidities like diabetes mellitus or spinal cord injury.
Viagra for Pulmonary Arterial Hypertension
Under the brand name Revatio (same active ingredient, different dosing), sildenafil is approved to improve exercise ability and delay clinical worsening in patients with WHO Group 1 pulmonary arterial hypertension. It helps reduce the workload on the right heart.
5. Instructions for Use: Dosage and Course of Administration
For erectile dysfunction, the recommended starting dose is 50 mg taken approximately one hour before sexual activity. Based on efficacy and tolerability, the dose may be increased to 100 mg or decreased to 25 mg. The maximum recommended dosing frequency is once per day. It can be taken with or without food, though high-fat meals may delay onset.
| Indication | Recommended Dose | Timing | Frequency |
|---|---|---|---|
| Erectile Dysfunction | 50 mg | ~1 hour before activity | As needed, max once daily |
| Erectile Dysfunction (dose adjustment) | 25 mg to 100 mg | ~1 hour before activity | As needed, max once daily |
| Pulmonary Arterial Hypertension (Revatio) | 20 mg | Three times daily | ~4-6 hours apart |
For PAH, the dose is 20 mg three times daily.
6. Contraindications and Drug Interactions with Viagra
Contraindications:
- Concomitant use of organic nitrates (e.g., nitroglycerin, isosorbide mononitrate) or nitric oxide donors in any form. This combination can cause severe, life-threatening hypotension.
- Known hypersensitivity to sildenafil or any component of the formulation.
- Concurrent use with guanylate cyclase stimulators (e.g., riociguat).
Significant Drug Interactions:
- Nitrates: Absolute contraindication due to risk of profound hypotension.
- Alpha-blockers (e.g., doxazosin, tamsulosin): Caution advised; can potentiate blood pressure-lowering effects. Initiate Viagra only after the patient has been stabilized on alpha-blocker therapy.
- Potent CYP3A4 Inhibitors (e.g., ketoconazole, ritonavir, erythromycin): May significantly increase sildenafil concentrations. A maximum Viagra dose of 25 mg within a 48-hour period is recommended.
- Antihypertensives: Additive blood pressure-lowering effects are possible.
Common side effects include headache, flushing, dyspepsia, nasal congestion, dizziness, and visual disturbances (blue-tinged vision, increased light sensitivity). These are typically mild to moderate and transient.
7. Clinical Studies and Evidence Base for Viagra
The efficacy of Viagra for ED is supported by numerous randomized, double-blind, placebo-controlled trials. In one pivotal study of 532 men with ED, 69% of patients receiving 100 mg of sildenafil reported improved erections, compared to 22% on placebo (Goldstein et al., 1998, JAMA). Improvements were demonstrated across various etiologies and severities.
For PAH, the SUPER-1 trial demonstrated that sildenafil (20 mg, 40 mg, or 80 mg TID) significantly improved six-minute walk distance (6MWD) by 45-50 meters compared to placebo after 12 weeks (Galiè et al., 2005, NEJM). It also reduced pulmonary arterial pressure and delayed clinical worsening.
Long-term studies have confirmed the sustained efficacy and safety profile of sildenafil over several years of use.
8. Comparing Viagra with Similar Products and Choosing a Quality Product
Viagra was the first PDE5 inhibitor. Other members of this class include:
- Cialis (tadalafil): Has a longer half-life (~17.5 hours), allowing for once-daily dosing or on-demand use with a longer window of opportunity (up to 36 hours).
- Levitra (vardenafil) & Stendra (avanafil): Similar to sildenafil in half-life, though avanafil may have a faster onset.
The choice depends on individual patient factors: frequency of sexual activity, desire for spontaneity, side effect profile, cost, and concomitant medications. Only obtain prescription medications from licensed pharmacies to ensure authenticity and quality.
9. Frequently Asked Questions (FAQ) about Viagra
What is the recommended course of Viagra to achieve results?
Viagra is taken on an as-needed basis for ED, not as a continuous “course.” It should be taken about one hour before sexual activity. For PAH, it is a chronic, three-times-daily therapy.
Can Viagra be combined with blood pressure medications?
It can be used with many antihypertensives but requires caution due to additive hypotensive effects. It is absolutely contraindicated with nitrates. A healthcare provider must manage this combination.
Does Viagra increase sexual desire?
No. Viagra does not affect libido. It only aids in achieving and maintaining an erection when the user is sexually stimulated.
Is Viagra safe for long-term use?
Long-term studies, some extending over 4 years, have shown that Viagra is generally safe for chronic use when prescribed appropriately and in the absence of new contraindications.
Can women use Viagra?
Viagra is not FDA-approved for treating sexual dysfunction in women. Studies have shown limited and inconsistent benefits for female sexual arousal disorder.
10. Conclusion: Validity of Viagra Use in Clinical Practice
Viagra remains a cornerstone treatment for erectile dysfunction and a valuable option in the management of pulmonary arterial hypertension. Its well-understood mechanism, robust clinical evidence base, and generally favorable safety profile support its continued use. The benefits for appropriate patients significantly outweigh the risks when prescribed and monitored correctly, solidifying its place in modern clinical practice.
I remember when the first samples of this compound, UK-92,480, arrived in our clinical research unit. We were all cardiologists then, focused on angina. The trial was a grind – meticulous dosing, endless ECGs. Frank, a 58-year-old post-MI patient on our protocol, pulled me aside during a follow-up. He was hesitant, almost embarrassed. “Doc,” he said, “the angina isn’t much better, but, uh… let’s just say things are working downstairs that haven’t worked in years.” We all dismissed it as an odd anecdote until Mike, another subject, said the same thing a week later. That’s when the murmurs started in the team.
The lead investigator, Dr. Alistair, was adamant we stick to the primary cardiac endpoints. He saw the ED reports as noise, a confounding variable. But a few of us, the junior clinicians, we’d have coffee and just couldn’t let it go. We’d seen too many men whose lives were shattered by ED after prostate surgery or with diabetes. There was no good solution. We started quietly pulling the files of men who’d reported the effect. The data was messy, subjective, but the signal was there. I had a huge argument with Alistair in his office; he called it “unscientific fishing,” I called it listening to the patients. The tension was palpable for weeks.
We pushed for a small, separate pilot. Our first dedicated ED patient was Robert, a 65-year-old with severe diabetic neuropathy. He’d been to every specialist. We gave him 50 mg. The next visit, his wife was with him, holding his hand. She was beaming. He just said, “Thank you.” That one moment validated the entire frustrating, contentious pivot. It wasn’t just about physiology; it was about dignity, relationships.
The real surprise came later, in long-term follow-up. We noticed something we hadn’t initially tracked: an improvement in the mood and general well-being of many of these men. It wasn’t just the sexual function; it was the restoration of a part of their identity. David, a 72-year-old widower who started dating again, told me it “gave me my confidence back.” That psychosocial component became a critical part of how I now counsel patients starting the therapy. The drug does the biochemistry, but the win is in the quality of life. I still get holiday cards from some of those early trial patients. They remind me that sometimes the most profound discoveries aren’t the ones you’re looking for, but the ones your patients show you.